Literature DB >> 10073864

Erectile dysfunction and sildenafil citrate and cardiologists.

R A Kloner, J P Jarow.   

Abstract

Since the release of sildenafil citrate (Viagra), increasing numbers of patients are seeking treatment for erectile dysfunction (ED). Many of the risk factors for ED are the same as those for cardiac disease. Sildenafil citrate is a highly effective oral agent for ED. It is absolutely contraindicated in patients receiving organic nitrates. The issue of cardiac deaths associated with sildenafil citrate and ways of potentially minimizing these cases are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073864     DOI: 10.1016/s0002-9149(98)00916-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

Review 1.  Erectile dysfunction in patients with cardiovascular disease.

Authors:  A J M Oude Ophuis; A A B Lycklama À Nijeholt
Journal:  Neth Heart J       Date:  2006-04       Impact factor: 2.380

2.  Pharmacotherapy of sexual dysfunctions : current status.

Authors:  Ajith Avasthi; Parthasarathy Biswas
Journal:  Indian J Psychiatry       Date:  2004-07       Impact factor: 1.759

3.  A prospective study of the effect of antihypertensive medications on the sexual functions of hypertensive adult male patients.

Authors:  Akinwumi Akinyinka Akinyede; Obiyo Nwaiwu; Olumuyiwa John Fasipe; Adedunni Olusanya; Sunday Olufemi Olayemi; Bisola Akande
Journal:  Future Sci OA       Date:  2020-06-02

Review 4.  Assessment of cardiovascular risk in patients with erectile dysfunction: focus on the diabetic patient.

Authors:  Robert A Kloner
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

5.  Ventricular fibrillation development following atrial fibrillation after the ingestion of sildenaphil in a patient with Wolff-Parkinson-White syndrome.

Authors:  Sinan Inci; Ibrahim Izgu; Halil Aktas; Pinar Dogan; Ali Dogan
Journal:  Intractable Rare Dis Res       Date:  2015-08

6.  Discussing sexual function in the cardiology practice.

Authors:  M P J Nicolai; S Both; S S Liem; R C M Pelger; H Putter; M J Schalij; H W Elzevier
Journal:  Clin Res Cardiol       Date:  2013-02-08       Impact factor: 5.460

7.  Intracranial aneurysm and sildenafil.

Authors:  Avinash Adiga; Hawa Edriss; Kenneth Nugent
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-04

Review 8.  Erectile dysfunction in the cardiac patient.

Authors:  Robert A Kloner
Journal:  Curr Urol Rep       Date:  2003-12       Impact factor: 3.092

9.  Effects of chronic type 5 phosphodiesterase inhibition on penile microvascular reactivity in hypertensive patients with erectile dysfunction: a randomized crossover placebo-controlled trial.

Authors:  Valéria Verri; Alessandro R Nascimento; Andrea A Brandao; Eduardo Tibirica
Journal:  J Hum Hypertens       Date:  2020-05-04       Impact factor: 3.012

Review 10.  Sexual function in hypertensive patients receiving treatment.

Authors:  Thorsten Reffelmann; Robert A Kloner
Journal:  Vasc Health Risk Manag       Date:  2006
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.